Tension-type headache

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Tension-type headache. / Bendtsen, Lars; Jensen, Rigmor; Bendtsen, Lars; Jensen, Rigmor.

In: Neurologic Clinics, Vol. 27, No. 2, 2009, p. 525-35.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Bendtsen, L, Jensen, R, Bendtsen, L & Jensen, R 2009, 'Tension-type headache', Neurologic Clinics, vol. 27, no. 2, pp. 525-35. https://doi.org/10.1016/j.ncl.2008.11.010, https://doi.org/10.1016/j.ncl.2008.11.010

APA

Bendtsen, L., Jensen, R., Bendtsen, L., & Jensen, R. (2009). Tension-type headache. Neurologic Clinics, 27(2), 525-35. https://doi.org/10.1016/j.ncl.2008.11.010, https://doi.org/10.1016/j.ncl.2008.11.010

Vancouver

Bendtsen L, Jensen R, Bendtsen L, Jensen R. Tension-type headache. Neurologic Clinics. 2009;27(2):525-35. https://doi.org/10.1016/j.ncl.2008.11.010, https://doi.org/10.1016/j.ncl.2008.11.010

Author

Bendtsen, Lars ; Jensen, Rigmor ; Bendtsen, Lars ; Jensen, Rigmor. / Tension-type headache. In: Neurologic Clinics. 2009 ; Vol. 27, No. 2. pp. 525-35.

Bibtex

@article{5dfc4d90a92e11df928f000ea68e967b,
title = "Tension-type headache",
abstract = "The substantial societal and individual burdens associated with tension-type headache (TTH) constitute a previously overlooked major public health issue. TTH is prevalent, affecting up to 78% of the general population, and 3% suffer from chronic TTH. Pericranial myofascial nociception probably is important for the pathophysiology of episodic TTH, whereas sensitization of central nociceptive pathways seems responsible for the conversion of episodic to chronic TTH. Headache-related disability usually can be reduced by identification of trigger factors combined with nonpharmacologic and pharmacologic treatments, but effective treatment modalities are lacking. Benefits can be gained by development of specific and effective treatment strategies.",
author = "Lars Bendtsen and Rigmor Jensen and Lars Bendtsen and Rigmor Jensen",
note = "Keywords: Humans; Neural Pathways; Pain Measurement; Prognosis; Tension-Type Headache; Time Factors; Treatment Outcome",
year = "2009",
doi = "10.1016/j.ncl.2008.11.010",
language = "English",
volume = "27",
pages = "525--35",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B.Saunders Co.",
number = "2",

}

RIS

TY - JOUR

T1 - Tension-type headache

AU - Bendtsen, Lars

AU - Jensen, Rigmor

AU - Bendtsen, Lars

AU - Jensen, Rigmor

N1 - Keywords: Humans; Neural Pathways; Pain Measurement; Prognosis; Tension-Type Headache; Time Factors; Treatment Outcome

PY - 2009

Y1 - 2009

N2 - The substantial societal and individual burdens associated with tension-type headache (TTH) constitute a previously overlooked major public health issue. TTH is prevalent, affecting up to 78% of the general population, and 3% suffer from chronic TTH. Pericranial myofascial nociception probably is important for the pathophysiology of episodic TTH, whereas sensitization of central nociceptive pathways seems responsible for the conversion of episodic to chronic TTH. Headache-related disability usually can be reduced by identification of trigger factors combined with nonpharmacologic and pharmacologic treatments, but effective treatment modalities are lacking. Benefits can be gained by development of specific and effective treatment strategies.

AB - The substantial societal and individual burdens associated with tension-type headache (TTH) constitute a previously overlooked major public health issue. TTH is prevalent, affecting up to 78% of the general population, and 3% suffer from chronic TTH. Pericranial myofascial nociception probably is important for the pathophysiology of episodic TTH, whereas sensitization of central nociceptive pathways seems responsible for the conversion of episodic to chronic TTH. Headache-related disability usually can be reduced by identification of trigger factors combined with nonpharmacologic and pharmacologic treatments, but effective treatment modalities are lacking. Benefits can be gained by development of specific and effective treatment strategies.

U2 - 10.1016/j.ncl.2008.11.010

DO - 10.1016/j.ncl.2008.11.010

M3 - Journal article

C2 - 19289230

VL - 27

SP - 525

EP - 535

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 2

ER -

ID: 21406336